Table 2: Evaluation of curability according to tumor-related
factors based on the JGES [16].
|
eCuraA |
eCuraB |
eCuraC-2 |
||||||
Histology |
Differentiated |
Differentiated |
Undifferentiated |
Differentiated |
Differentiated |
Undifferentiated |
Differentiated |
Undifferentiated |
Any |
Size in cm |
Any |
≤3 |
≥2 |
≤3 |
>3 |
>2 |
>3 |
Any |
Any |
Ulceration |
Negative |
Positive |
Negative |
Any |
Positive |
Negative |
Any |
Positive |
Any |
Invasion |
pT1a(M) |
pT1a(M) |
pT1a(M) |
pT1b1(SM1) |
pT1a(M) |
pT1a(M) |
pT1b1(SM1) |
pT1a(M) |
pT1b2(SM2) |
pT1a (M): Intramucosal cancer (histopathological
diagnosis); pT1b (SM): Submucosally invasive cancer (histopathological
diagnosis).